Advisors Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Sell |
5,239
-1,646
| -24% | -$80.1K | ﹤0.01% | 1079 |
|
|
2025
Q1 | $234K | Sell |
6,885
-839
| -11% | -$28.6K | ﹤0.01% | 1080 |
|
|
2024
Q4 | $304K | Sell |
7,724
-1,945
| -20% | -$76.6K | 0.01% | 1039 |
|
|
2024
Q3 | $454K | Buy |
9,669
+342
| +4% | +$16.1K | 0.01% | 961 |
|
|
2024
Q2 | $504K | Sell |
9,327
-135
| -1% | -$7.29K | 0.01% | 900 |
|
|
2024
Q1 | $645K | Buy |
9,462
+2,814
| +42% | +$192K | 0.01% | 842 |
|
|
2023
Q4 | $416K | Sell |
6,648
-570
| -8% | -$35.7K | 0.01% | 948 |
|
|
2023
Q3 | $328K | Buy |
7,218
+1,507
| +26% | +$68.4K | 0.01% | 1013 |
|
|
2023
Q2 | $321K | Sell |
5,711
-6,094
| -52% | -$342K | 0.01% | 1034 |
|
|
2023
Q1 | $534K | Sell |
11,805
-100
| -0.8% | -$4.52K | 0.01% | 917 |
|
|
2022
Q4 | $484K | Sell |
11,905
-10,509
| -47% | -$427K | 0.01% | 932 |
|
|
2022
Q3 | $1.47M | Sell |
22,414
-1,481
| -6% | -$96.8K | 0.03% | 589 |
|
|
2022
Q2 | $1.45M | Sell |
23,895
-3,775
| -14% | -$229K | 0.03% | 624 |
|
|
2022
Q1 | $1.74M | Sell |
27,670
-9,307
| -25% | -$584K | 0.03% | 630 |
|
|
2021
Q4 | $2.8M | Sell |
36,977
-817
| -2% | -$61.9K | 0.04% | 489 |
|
|
2021
Q3 | $4.23M | Buy |
37,794
+3,702
| +11% | +$414K | 0.06% | 314 |
|
|
2021
Q2 | $5.52M | Buy |
34,092
+5,284
| +18% | +$855K | 0.08% | 243 |
|
|
2021
Q1 | $3.51M | Buy |
28,808
+12,024
| +72% | +$1.47M | 0.05% | 369 |
|
|
2020
Q4 | $2.57M | Buy |
16,784
+13,251
| +375% | +$2.03M | 0.04% | 437 |
|
|
2020
Q3 | $296K | Buy |
3,533
+1,636
| +86% | +$137K | 0.01% | 1071 |
|
|
2020
Q2 | $139K | Buy |
+1,897
| New | +$139K | ﹤0.01% | 1246 |
|